{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T08:21:43Z","timestamp":1787905303847,"version":"build-2784847793"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32260159"],"award-info":[{"award-number":["32260159"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360725"],"award-info":[{"award-number":["82360725"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007471","name":"Applied Basic Research Foundation of Yunnan Province","doi-asserted-by":"publisher","award":["202301AS070022"],"award-info":[{"award-number":["202301AS070022"]}],"id":[{"id":"10.13039\/100007471","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Prod. Bioprospect."],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s13659-026-00628-w","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T07:58:32Z","timestamp":1787903912000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u03b2-carboline derivative Z86 alleviates pulmonary fibrosis via suppressing TGF-\u03b2\/Smad signaling"],"prefix":"10.1007","volume":"16","author":[{"given":"Yuyang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingmei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"issue":"2","key":"628_CR1","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1021\/acs.jmedchem.6b00935","volume":"60","author":"YM Liu","year":"2017","unstructured":"Liu YM, Nepali K, Liou JP. Idiopathic Pulmonary Fibrosis: current status, recent progress, and emerging targets. J Med Chem. 2017;60(2):527\u201353.","journal-title":"J Med Chem"},{"key":"628_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107839","volume":"225","author":"G Liu","year":"2021","unstructured":"Liu G, Philp AM, Corte T, Travis MA, Schilter H, Hansbro NG, et al. Therapeutic targets in lung tissue remodelling and fibrosis. Pharmacol Ther. 2021;225:107839.","journal-title":"Pharmacol Ther"},{"key":"628_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1205948","volume":"14","author":"H Guo","year":"2023","unstructured":"Guo H, Sun J, Zhang S, Nie Y, Zhou S, Zeng Y. Progress in understanding and treating Idiopathic Pulmonary Fibrosis: recent insights and emerging therapies. Front Pharmacol. 2023;14:1205948.","journal-title":"Front Pharmacol"},{"issue":"Suppl 14","key":"628_CR4","doi-asserted-by":"publisher","first-page":"S1740","DOI":"10.21037\/jtd.2019.04.62","volume":"11","author":"S Saito","year":"2019","unstructured":"Saito S, Alkhatib A, Kolls JK, Kondoh Y, Lasky JA. Pharmacotherapy and adjunctive treatment for Idiopathic Pulmonary Fibrosis (IPF). J Thorac Dis. 2019;11(Suppl 14):S1740\u201354.","journal-title":"J Thorac Dis"},{"key":"628_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107798","volume":"222","author":"P Spagnolo","year":"2021","unstructured":"Spagnolo P, Kropski JA, Jones MG, Lee JS, Rossi G, Karampitsakos T, et al. Idiopathic pulmonary fibrosis: Disease mechanisms and drug development. Pharmacol Ther. 2021;222:107798.","journal-title":"Pharmacol Ther"},{"issue":"5","key":"628_CR6","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s40265-021-01487-0","volume":"81","author":"YN Lamb","year":"2021","unstructured":"Lamb YN. Nintedanib: a review in fibrotic interstitial lung diseases. Drugs. 2021;81(5):575\u201386.","journal-title":"Drugs"},{"issue":"9","key":"628_CR7","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1007\/s11010-023-04845-6","volume":"479","author":"P Saha","year":"2024","unstructured":"Saha P, Talwar P. Idiopathic Pulmonary Fibrosis (IPF): disease pathophysiology, targets, and potential therapeutic interventions. Mol Cell Biochem. 2024;479(9):2181\u201394.","journal-title":"Mol Cell Biochem"},{"key":"628_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/medicina55040083","author":"F Salton","year":"2019","unstructured":"Salton F, Volpe MC, Confalonieri M. Epithelial(-)mesenchymal transition in the pathogenesis of idiopathic pulmonary fibrosis. Medicina (Kaunas). 2019. https:\/\/doi.org\/10.3390\/medicina55040083.","journal-title":"Medicina (Kaunas)"},{"key":"628_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2020.105802","volume":"126","author":"Z Deng","year":"2020","unstructured":"Deng Z, Fear MW, Suk Choi Y, Wood FM, Allahham A, Mutsaers SE, et al. The extracellular matrix and mechanotransduction in pulmonary fibrosis. Int J Biochem Cell Biol. 2020;126:105802.","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"628_CR10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1165\/rcmb.2021-0342TR","volume":"66","author":"CA Staab-Weijnitz","year":"2022","unstructured":"Staab-Weijnitz CA. Fighting the fiber: targeting collagen in lung fibrosis. Am J Respir Cell Mol Biol. 2022;66(4):363\u201381.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"628_CR11","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12931-023-02608-x","volume":"24","author":"F Thiam","year":"2023","unstructured":"Thiam F, Phogat S, Abokor FA, Osei ET. In vitro co-culture studies and the crucial role of fibroblast-immune cell crosstalk in IPF pathogenesis. Respir Res. 2023;24(1):298.","journal-title":"Respir Res"},{"key":"628_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22116107","author":"N Inui","year":"2021","unstructured":"Inui N, Sakai S, Kitagawa M. Molecular pathogenesis of pulmonary fibrosis, with focus on pathways related to TGF-beta and the ubiquitin-proteasome pathway. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22116107.","journal-title":"Int J Mol Sci"},{"key":"628_CR13","doi-asserted-by":"crossref","unstructured":"Ye Z, Hu Y. TGF\u2011beta1: Gentlemanly orchestrator in idiopathic pulmonary fibrosis (Review). Int J Mol Med. 2021;48(1).","DOI":"10.3892\/ijmm.2021.4965"},{"issue":"1","key":"628_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s10020-024-00984-8","volume":"30","author":"R Zhu","year":"2024","unstructured":"Zhu R, Li M, Wang D, Liu C, Xie L, Yang Y, et al. USP15 regulates radiation-induced DNA damage and intestinal injury through K48-linked deubiquitination and stabilisation of ATM. Mol Med. 2024;30(1):205.","journal-title":"Mol Med"},{"issue":"19","key":"628_CR15","doi-asserted-by":"publisher","first-page":"11093","DOI":"10.1093\/nar\/gkac823","volume":"50","author":"C Shi","year":"2022","unstructured":"Shi C, Yang X, Hou Y, Jin X, Guo L, Zhou Y, et al. USP15 promotes cGAS activation through deubiquitylation and liquid condensation. Nucleic Acids Res. 2022;50(19):11093\u2013108.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"628_CR16","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.ajpath.2019.03.005","volume":"189","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Wang Z, Ho C, Zhang G, Li Q. Ubiquitin-specific protease 15 maintains Transforming Growth Factor-beta pathway activity by deubiquitinating Transforming Growth Factor-beta Receptor I during wound healing. Am J Pathol. 2019;189(7):1351\u201362.","journal-title":"Am J Pathol"},{"issue":"5","key":"628_CR17","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1097\/PRS.0000000000008488","volume":"148","author":"L Tu","year":"2021","unstructured":"Tu L, Lin Z, Huang Q, Liu D. USP15 enhances the proliferation, migration, and collagen deposition of hypertrophic scar-derived fibroblasts by deubiquitinating TGF-betaR1 in vitro. Plast Reconstr Surg. 2021;148(5):1040\u201351.","journal-title":"Plast Reconstr Surg"},{"key":"628_CR18","doi-asserted-by":"publisher","first-page":"15033","DOI":"10.1038\/cddiscovery.2015.33","volume":"1","author":"X Li","year":"2015","unstructured":"Li X, Bai B, Liu L, Ma P, Kong L, Yan J, et al. Novel beta-carbolines against colorectal cancer cell growth via inhibition of Wnt\/beta-catenin signaling. Cell Death Discov. 2015;1:15033.","journal-title":"Cell Death Discov"},{"issue":"1","key":"628_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s13659-023-00422-y","volume":"14","author":"S Nie","year":"2024","unstructured":"Nie S, Chang L, Huang Y, Zhou H, Yang Q, Kong L, et al. beta-carboline derivative Z86 attenuates colorectal cancer cell proliferation and migration by directly targeting PI3K. Nat Prod Bioprospect. 2024;14(1):3.","journal-title":"Nat Prod Bioprospect"},{"issue":"5","key":"628_CR20","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.amjms.2019.02.009","volume":"357","author":"A Barros","year":"2019","unstructured":"Barros A, Oldham J, Noth I. Genetics of Idiopathic Pulmonary Fibrosis. Am J Med Sci. 2019;357(5):379\u201383.","journal-title":"Am J Med Sci"},{"key":"628_CR21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.mam.2018.08.004","volume":"65","author":"D Chanda","year":"2019","unstructured":"Chanda D, Otoupalova E, Smith SR, Volckaert T, De Langhe SP, Thannickal VJ. Developmental pathways in the pathogenesis of lung fibrosis. Mol Aspects Med. 2019;65:56\u201369.","journal-title":"Mol Aspects Med"},{"issue":"12","key":"628_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.402","volume":"7","author":"XM Meng","year":"2016","unstructured":"Meng XM, Wang S, Huang XR, Yang C, Xiao J, Zhang Y, et al. Inflammatory macrophages can transdifferentiate into myofibroblasts during renal fibrosis. Cell Death Dis. 2016;7(12):e2495.","journal-title":"Cell Death Dis"},{"key":"628_CR23","doi-asserted-by":"publisher","DOI":"10.1017\/S1462399411001967","volume":"13","author":"K Kis","year":"2011","unstructured":"Kis K, Liu X, Hagood JS. Myofibroblast differentiation and survival in fibrotic disease. Expert Rev Mol Med. 2011;13:e27.","journal-title":"Expert Rev Mol Med"},{"issue":"9","key":"628_CR24","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/cbin.10788","volume":"41","author":"L Zhu","year":"2017","unstructured":"Zhu L, Fu X, Chen X, Han X, Dong P. M2 macrophages induce EMT through the TGF-beta\/Smad2 signaling pathway. Cell Biol Int. 2017;41(9):960\u20138.","journal-title":"Cell Biol Int"},{"issue":"3","key":"628_CR25","doi-asserted-by":"publisher","first-page":"L585","DOI":"10.1152\/ajplung.00151.2001","volume":"282","author":"J Zhao","year":"2002","unstructured":"Zhao J, Shi W, Wang YL, Chen H, Bringas P Jr, Datto MB, et al. Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol. 2002;282(3):L585\u201393.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"628_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1165\/rcmb.2014-0445OC","volume":"54","author":"S Rangarajan","year":"2016","unstructured":"Rangarajan S, Kurundkar A, Kurundkar D, Bernard K, Sanders YY, Ding Q, et al. Novel Mechanisms for the Antifibrotic Action of Nintedanib. Am J Respir Cell Mol Biol. 2016;54(1):51\u20139.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"628_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/cph4.70013","volume":"15","author":"J Shen","year":"2025","unstructured":"Shen J, Jiang Y, Bu W, Yu M, Huang R, Tang C, et al. Protein Ubiquitination Modification in Pulmonary Fibrosis. Compr Physiol. 2025;15(3):e70013.","journal-title":"Compr Physiol"},{"issue":"187","key":"628_CR28","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.24976\/Discov.Med.202436187.148","volume":"36","author":"F Tang","year":"2024","unstructured":"Tang F, Gong H, Ke T, Yang W, Yang Y, Liu Z. USP7 promotes TGF-beta1 signaling by de-ubiquitinating Smad2\/Smad3 in pulmonary fibrosis. Discov Med. 2024;36(187):1616\u201326.","journal-title":"Discov Med"}],"container-title":["Natural Products and Bioprospecting"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13659-026-00628-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13659-026-00628-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13659-026-00628-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T07:58:33Z","timestamp":1787903913000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13659-026-00628-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["628"],"URL":"https:\/\/doi.org\/10.1007\/s13659-026-00628-w","relation":{},"ISSN":["2192-2195","2192-2209"],"issn-type":[{"value":"2192-2195","type":"print"},{"value":"2192-2209","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"assertion":[{"value":"7 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"84"}}